fbpx
QQQ
+ 0.00
344.36
+ 0%
DIA
-0.05
338.83
-0.01%
SPY
-0.12
420.98
-0.03%
TLT
+ 0.00
143.29
+ 0%
GLD
-0.02
166.97
-0.01%

LAVA Therapeutics Shares Resume Trading, Continue Higher; Up 23%

March 31, 2021 11:24 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.



Start your FREE 14-day trial of Benzinga Pro today.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.

Posted-In:

Movers Trading Ideas

Related Articles

48 Biggest Movers From Yesterday

Gainers Welbilt, Inc. (NYSE: WBT) shares surged 44.5% to close at $22.58 on Wednesday after The Middleby Corporation announced plans to acquire the company. read more

Why Is It Moving? Looking At LAVA Therapeutics's Price Action Today

LAVA Therapeutics's Stock Price And Volume Action LAVA Therapeutics's (NASDAQ:LVTX) stock is trading up 1.0% to a price of $15.15. The stock's volume is currently 9.22 thousand, which is roughly 3.05% of its recent 30-day volume average of 301.72 thousand. read more

48 Biggest Movers From Thursday

Gainers AeroCentury Corp. (NYSE: ACY) jumped 173.2% to close at $9.70 on Thursday. The company recently reported that it filed a petition for a Chapter 11 reorganization. read more

LAVA Therapeutics Shares Halted On Circuit Breaker; Up 23%